Skip to main content
Erschienen in: Immunologic Research 2/2017

28.01.2017 | Novel Aspects in Lupus, 2017

Prolactin has a pathogenic role in systemic lupus erythematosus

verfasst von: Luis J. Jara, Gabriela Medina, Miguel A. Saavedra, Olga Vera-Lastra, Honorio Torres-Aguilar, Carmen Navarro, Monica Vazquez del Mercado, Luis R. Espinoza

Erschienen in: Immunologic Research | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

Prolactin, a 23-kDa peptide hormone, is produced by the anterior pituitary gland and extrapituitary sites including the immune cells. Prolactin (PRL) participates in innate and adaptive immune response. PRL stimulates the immune cells by binding to receptor (PRL-R). Binding of PRL to its receptor activates the Janus kinase-signal transducer (JAK-STAT). Activation of these cascades results in endpoints such as immunoestimulator and immunosupressor action. Prolactin belongs to the network of immune-neuroendocrine interaction. Hyperprolactinemia has been found in patients with systemic lupus erythematosus (SLE), and new evidence has confirmed a significant correlation between serum PRL levels and disease activity. PRL participates in activation of SLE during pregnancy and in pathogenesis of lupus nephritis, neuropsychiatric, serosal, hematologic, articular, and cutaneous involvement. Hyperprolactinemia was associated with increase IgG concentrations, anti-DNA antibodies, immune complex, glomerulonephritis, and accelerated mortality in murine lupus. Bromocriptine, a dopamine analog that suppresses PRL secretion, was associated with decreased lupus activity, prolonged lifespan, and restoration of immune competence in experimental model. In clinical trials, bromocriptine and derivative drugs showed beneficial therapeutic effect in treating human lupus, including pregnancy. Taken together, clinical and experimental results leave little doubt that PRL indeed contributes to the pathogenesis and clinical expression of SLE.
https://static-content.springer.com/image/art%3A10.1007%2Fs12026-016-8891-x/MediaObjects/12026_2016_8891_Figa_HTML.gif
Literatur
1.
Zurück zum Zitat Afanasyeva M, Rose RN. Viral infection and heart disease: autoimmune mechanisms. In: Shoenfeld Y, Rose NR, editors. Infections and autoimmunity. The Netherlands: Elsevier B.V.; 2004. pp. 299–318. Afanasyeva M, Rose RN. Viral infection and heart disease: autoimmune mechanisms. In: Shoenfeld Y, Rose NR, editors. Infections and autoimmunity. The Netherlands: Elsevier B.V.; 2004. pp. 299–318.
2.
Zurück zum Zitat Dar AA, Patil RS, Chiplunkar SV. Insights into the relationship between toll like receptors and gamma delta T cell responses. Front Immunol. 2014;5:366.PubMedPubMedCentralCrossRef Dar AA, Patil RS, Chiplunkar SV. Insights into the relationship between toll like receptors and gamma delta T cell responses. Front Immunol. 2014;5:366.PubMedPubMedCentralCrossRef
3.
Zurück zum Zitat Besedovsky HO, del Rey A. Immune-neuro-endocrine interactions: facts and hypotheses. Endocr Rev. 1996;17:64–102.PubMedCrossRef Besedovsky HO, del Rey A. Immune-neuro-endocrine interactions: facts and hypotheses. Endocr Rev. 1996;17:64–102.PubMedCrossRef
4.
Zurück zum Zitat Jara LJ, Lavalle C, Espinoza LR. Does prolactin have a role in the pathogenesis of systemic lupus erythematosus? J Rheumatol. 1992;19:1333–6.PubMed Jara LJ, Lavalle C, Espinoza LR. Does prolactin have a role in the pathogenesis of systemic lupus erythematosus? J Rheumatol. 1992;19:1333–6.PubMed
5.
Zurück zum Zitat Szyper-Kravitz M, Zandman-Goddard G, Lahita RG, Shoenfeld Y. The neuroendocrine-immune interactions in systemic lupus erythematosus: a basis for understanding disease pathogenesis and complexity. Rheum Dis Clin N Am. 2005;31:161–75.CrossRef Szyper-Kravitz M, Zandman-Goddard G, Lahita RG, Shoenfeld Y. The neuroendocrine-immune interactions in systemic lupus erythematosus: a basis for understanding disease pathogenesis and complexity. Rheum Dis Clin N Am. 2005;31:161–75.CrossRef
6.
Zurück zum Zitat Berczi I, Bertok L, Chow DA. Natural immunity and neuroimmune host defense. Ann N Y Acad Sci. 2000;917:248–57.PubMedCrossRef Berczi I, Bertok L, Chow DA. Natural immunity and neuroimmune host defense. Ann N Y Acad Sci. 2000;917:248–57.PubMedCrossRef
7.
Zurück zum Zitat Wilder RL. Neuroendocrine-immune system interactions and autoimmunity. Annu Rev Immunol. 1995;13:307–38.PubMedCrossRef Wilder RL. Neuroendocrine-immune system interactions and autoimmunity. Annu Rev Immunol. 1995;13:307–38.PubMedCrossRef
8.
Zurück zum Zitat De Bellis A, Bizzarro A, Pivonello R, Lombardi G, Bellastella A. Prolactin and autoimmunity. Pituitary. 2005;8:25–30.PubMedCrossRef De Bellis A, Bizzarro A, Pivonello R, Lombardi G, Bellastella A. Prolactin and autoimmunity. Pituitary. 2005;8:25–30.PubMedCrossRef
9.
Zurück zum Zitat Breuel KF, Kougias P, Rice PJ, Wei D, De Ponti K, Wang J, et al. Anterior pituitary cells express pattern recognition receptors for fungal glucans: implications for neuroendocrine immune involvement in response to fungal infections. Neuroimmunomodulation. 2004;11:1–9.PubMedCrossRef Breuel KF, Kougias P, Rice PJ, Wei D, De Ponti K, Wang J, et al. Anterior pituitary cells express pattern recognition receptors for fungal glucans: implications for neuroendocrine immune involvement in response to fungal infections. Neuroimmunomodulation. 2004;11:1–9.PubMedCrossRef
10.
Zurück zum Zitat Peña B, Isla A, Haussmann D, Figueroa J. Immunostimulatory effect of salmon prolactin on expression of toll-like receptors in Oncorhynchus mykiss infected with Piscirickettsia salmonis. Fish Physiol Biochem. 2016;42:509–16.PubMedCrossRef Peña B, Isla A, Haussmann D, Figueroa J. Immunostimulatory effect of salmon prolactin on expression of toll-like receptors in Oncorhynchus mykiss infected with Piscirickettsia salmonis. Fish Physiol Biochem. 2016;42:509–16.PubMedCrossRef
11.
Zurück zum Zitat Corbacho AM, Valacchi G, Kubala L, Olano-Martín E, Schock BC, Kenny TP, et al. Tissue-specific gene expression of prolactin receptor in the acute-phase response induced by lipopolysaccharides. Am J Physiol Endocrinol Metab. 2004;287:E750–7.PubMedCrossRef Corbacho AM, Valacchi G, Kubala L, Olano-Martín E, Schock BC, Kenny TP, et al. Tissue-specific gene expression of prolactin receptor in the acute-phase response induced by lipopolysaccharides. Am J Physiol Endocrinol Metab. 2004;287:E750–7.PubMedCrossRef
12.
Zurück zum Zitat Meli R, Raso GM, Gualillo O, Pacilio M, Di Carlo RR. Prolactin modulation of nitric oxide and TNF-alpha production by peripheral neutrophils in rats. Life Sci. 1997;61:1395–403.PubMedCrossRef Meli R, Raso GM, Gualillo O, Pacilio M, Di Carlo RR. Prolactin modulation of nitric oxide and TNF-alpha production by peripheral neutrophils in rats. Life Sci. 1997;61:1395–403.PubMedCrossRef
13.
Zurück zum Zitat Dal Secco D, Paron JA, de Oliveira SH, Ferreira SH, Silva JS, Cunha FQ. Neutrophil migration in inflammation: nitric oxide inhibits rolling, adhesion and induces apoptosis. Nitric Oxide. 2003;9:153–64.PubMedCrossRef Dal Secco D, Paron JA, de Oliveira SH, Ferreira SH, Silva JS, Cunha FQ. Neutrophil migration in inflammation: nitric oxide inhibits rolling, adhesion and induces apoptosis. Nitric Oxide. 2003;9:153–64.PubMedCrossRef
14.
Zurück zum Zitat Olson KK, Townson DH. Prolactin-induced expression of intercellular adhesion molecule-1 and the accumulation of monocytes/macrophages during regression of the rat corpus luteum. Biol Reprod. 2000;62:1571–8.PubMedCrossRef Olson KK, Townson DH. Prolactin-induced expression of intercellular adhesion molecule-1 and the accumulation of monocytes/macrophages during regression of the rat corpus luteum. Biol Reprod. 2000;62:1571–8.PubMedCrossRef
15.
Zurück zum Zitat Kawaguchi R, Shimokawa T, Umehara N, Nunomura S, Tanaka T, Ra C. Priming of peripheral monocytes with prolactin (PRL) sensitizes IFN-gamma-mediated indoleamine 2,3-dioxygenase (IDO) expression without affecting IFN-gamma signaling. J Reprod Immunol. 2008;77:117–25.PubMedCrossRef Kawaguchi R, Shimokawa T, Umehara N, Nunomura S, Tanaka T, Ra C. Priming of peripheral monocytes with prolactin (PRL) sensitizes IFN-gamma-mediated indoleamine 2,3-dioxygenase (IDO) expression without affecting IFN-gamma signaling. J Reprod Immunol. 2008;77:117–25.PubMedCrossRef
16.
Zurück zum Zitat Torres-Aguilar H, Blank M, Jara LJ, Shoenfeld Y. Tolerogenic dendritic cells in autoimmune diseases: crucial players in induction and prevention of autoimmunity. Autoimmun Rev. 2010;10:8–17.PubMedCrossRef Torres-Aguilar H, Blank M, Jara LJ, Shoenfeld Y. Tolerogenic dendritic cells in autoimmune diseases: crucial players in induction and prevention of autoimmunity. Autoimmun Rev. 2010;10:8–17.PubMedCrossRef
17.
Zurück zum Zitat Matera L, Mori M, Galetto A. Effect of prolactin on the antigen presenting function of monocyte-derived dendritic cells. Lupus. 2001;10:728–34.PubMedCrossRef Matera L, Mori M, Galetto A. Effect of prolactin on the antigen presenting function of monocyte-derived dendritic cells. Lupus. 2001;10:728–34.PubMedCrossRef
18.
Zurück zum Zitat Triggianese P, Perricone C, Perricone R, De Carolis C. Prolactin and natural killer cells: evaluating the neuroendocrine-immune axis in women with primary infertility and recurrent spontaneous abortion. Am J Reprod Immunol. 2015;73:56–65.PubMedCrossRef Triggianese P, Perricone C, Perricone R, De Carolis C. Prolactin and natural killer cells: evaluating the neuroendocrine-immune axis in women with primary infertility and recurrent spontaneous abortion. Am J Reprod Immunol. 2015;73:56–65.PubMedCrossRef
19.
Zurück zum Zitat Gubbay O, Critchley HO, Bowen JM, King A, Jabbour HN. Prolactin induces ERK phosphorylation in epithelial and CD56(+) natural killer cells of the human endometrium. J Clin Endocrinol Metab. 2002;87:2329–35.PubMedCrossRef Gubbay O, Critchley HO, Bowen JM, King A, Jabbour HN. Prolactin induces ERK phosphorylation in epithelial and CD56(+) natural killer cells of the human endometrium. J Clin Endocrinol Metab. 2002;87:2329–35.PubMedCrossRef
20.
Zurück zum Zitat Francis K, Lewis BM, Akatsu H, Monk PN, Cain SA, Scanlon MF, et al. Complement C3a receptors in the pituitary gland: a novel pathway by which an innate immune molecule releases hormones involved in the control of inflammation. FASEB J. 2003;17:2266–8.PubMed Francis K, Lewis BM, Akatsu H, Monk PN, Cain SA, Scanlon MF, et al. Complement C3a receptors in the pituitary gland: a novel pathway by which an innate immune molecule releases hormones involved in the control of inflammation. FASEB J. 2003;17:2266–8.PubMed
21.
Zurück zum Zitat Brand JM, Frohn C, Cziupka K, Brockmann C, Kirchner H, Luhm J. Prolactin triggers pro-inflammatory immune responses in peripheral immune cells. Eur Cytokine Netw. 2004;15:99–104.PubMed Brand JM, Frohn C, Cziupka K, Brockmann C, Kirchner H, Luhm J. Prolactin triggers pro-inflammatory immune responses in peripheral immune cells. Eur Cytokine Netw. 2004;15:99–104.PubMed
22.
Zurück zum Zitat D’Isanto M, Vitiello M, Raieta K, Galdiero M, Galdiero M. Prolactin modulates IL-8 production induced by porins or LPS through different signaling mechanisms. Immunobiology. 2004;209:523–33.PubMedCrossRef D’Isanto M, Vitiello M, Raieta K, Galdiero M, Galdiero M. Prolactin modulates IL-8 production induced by porins or LPS through different signaling mechanisms. Immunobiology. 2004;209:523–33.PubMedCrossRef
23.
Zurück zum Zitat Montgomery DW, Shen GK, Ulrich ED, Steiner LL, Parrish PR, Zukoski CF. Human thymocytes express a prolactin-like messenger ribonucleic acid and synthesize bioactive prolactin-like proteins. Endocrinology. 1992;131:3019–26.PubMedCrossRef Montgomery DW, Shen GK, Ulrich ED, Steiner LL, Parrish PR, Zukoski CF. Human thymocytes express a prolactin-like messenger ribonucleic acid and synthesize bioactive prolactin-like proteins. Endocrinology. 1992;131:3019–26.PubMedCrossRef
24.
Zurück zum Zitat Pellegrini I, Lebrun JJ, Ali S, Kelly PA. Expression of prolactin and its receptor in human lymphoid cells. Mol Endocrinol. 1992;6:1023–31.PubMed Pellegrini I, Lebrun JJ, Ali S, Kelly PA. Expression of prolactin and its receptor in human lymphoid cells. Mol Endocrinol. 1992;6:1023–31.PubMed
25.
Zurück zum Zitat Horseman ND, Zhao W, Montecino-Rodriguez E, Tanaka M, Nakashima K, Engle SJ, et al. Defective mammopoiesis, but normal hematopoiesis, in mice with a targeted disruption of the prolactin gene. EMBO J. 1997;16:6926–35.PubMedPubMedCentralCrossRef Horseman ND, Zhao W, Montecino-Rodriguez E, Tanaka M, Nakashima K, Engle SJ, et al. Defective mammopoiesis, but normal hematopoiesis, in mice with a targeted disruption of the prolactin gene. EMBO J. 1997;16:6926–35.PubMedPubMedCentralCrossRef
26.
Zurück zum Zitat Dogusan Z, Hooghe R, Verdood P, Hooghe-Peters EL. Cytokine-like effects of prolactin in human mononuclear and polymorphonuclear leukocytes. J Neuroimmunol. 2001;120:58–66.PubMedCrossRef Dogusan Z, Hooghe R, Verdood P, Hooghe-Peters EL. Cytokine-like effects of prolactin in human mononuclear and polymorphonuclear leukocytes. J Neuroimmunol. 2001;120:58–66.PubMedCrossRef
27.
Zurück zum Zitat Lahat N, Miller A, Shtiller R, Touby E. Differential effects of prolactin upon activation and differentiation of human B lymphocytes. J Neuroimmunol. 1993;47:35–40.PubMedCrossRef Lahat N, Miller A, Shtiller R, Touby E. Differential effects of prolactin upon activation and differentiation of human B lymphocytes. J Neuroimmunol. 1993;47:35–40.PubMedCrossRef
28.
Zurück zum Zitat Matalka KZ. Prolactin enhances production of interferon-gamma, interleukin-12, and interleukin-10, but not of tumor necrosis factor-alpha, in a stimulus-specific manner. Cytokine. 2003;21:187–94.PubMedCrossRef Matalka KZ. Prolactin enhances production of interferon-gamma, interleukin-12, and interleukin-10, but not of tumor necrosis factor-alpha, in a stimulus-specific manner. Cytokine. 2003;21:187–94.PubMedCrossRef
29.
Zurück zum Zitat Matera L, Contarini M, Bellone G, Forno B, Biglino A. Up-modulation of interferon-gamma mediates the enhancement of spontanous cytotoxicity in prolactin-activated natural killer cells. Immunology. 1999;98:386–92.PubMedPubMedCentralCrossRef Matera L, Contarini M, Bellone G, Forno B, Biglino A. Up-modulation of interferon-gamma mediates the enhancement of spontanous cytotoxicity in prolactin-activated natural killer cells. Immunology. 1999;98:386–92.PubMedPubMedCentralCrossRef
30.
Zurück zum Zitat Leff MA, Buckley DJ, Krumenacker JS, Reed JC, Miyashita T, Buckley AR. Rapid modulation of the apoptosis regulatory genes, bcl-2 and bax by prolactin in rat Nb2 lymphoma cells. Endocrinology. 1996;137:5456–62.PubMedCrossRef Leff MA, Buckley DJ, Krumenacker JS, Reed JC, Miyashita T, Buckley AR. Rapid modulation of the apoptosis regulatory genes, bcl-2 and bax by prolactin in rat Nb2 lymphoma cells. Endocrinology. 1996;137:5456–62.PubMedCrossRef
31.
Zurück zum Zitat Krishnan N, Thellin O, Buckley DJ, Horseman ND, Buckley AR. Prolactin suppresses glucocorticoid-induced thymocyte apoptosis in vivo. Endocrinology. 2003;144:2102–10.PubMedCrossRef Krishnan N, Thellin O, Buckley DJ, Horseman ND, Buckley AR. Prolactin suppresses glucocorticoid-induced thymocyte apoptosis in vivo. Endocrinology. 2003;144:2102–10.PubMedCrossRef
32.
Zurück zum Zitat Zellweger R, Zhu XH, Wichmann MW, Ayala A, DeMaso CM, Chaudry IH. Prolactin administration following hemorrhagic shock improves macrophage cytokine release capacity and decreases mortality from subsequent sepsis. J Immunol. 1996;157:5748–54.PubMed Zellweger R, Zhu XH, Wichmann MW, Ayala A, DeMaso CM, Chaudry IH. Prolactin administration following hemorrhagic shock improves macrophage cytokine release capacity and decreases mortality from subsequent sepsis. J Immunol. 1996;157:5748–54.PubMed
33.
Zurück zum Zitat Dugan AL, Thellin O, Buckley DJ, Buckley AR, Ogle CK, Horseman ND. Effects of prolactin deficiency on myelopoiesis and splenic T lymphocyte proliferation in thermally injured mice. Endocrinology. 2002;143:4147–51.PubMedCrossRef Dugan AL, Thellin O, Buckley DJ, Buckley AR, Ogle CK, Horseman ND. Effects of prolactin deficiency on myelopoiesis and splenic T lymphocyte proliferation in thermally injured mice. Endocrinology. 2002;143:4147–51.PubMedCrossRef
34.
Zurück zum Zitat Gerlo S, Verdood P, Hooghe-Peters EL, Kooijman R. Modulation of prolactin expression in human T lymphocytes by cytokines. J Neuroimmunol. 2005;162:190–3.PubMedCrossRef Gerlo S, Verdood P, Hooghe-Peters EL, Kooijman R. Modulation of prolactin expression in human T lymphocytes by cytokines. J Neuroimmunol. 2005;162:190–3.PubMedCrossRef
35.
Zurück zum Zitat Takizawa K, Kitani S, Takeuchi F, Yamamoto K. Enhanced expression of CD69 and CD25 antigen on human peripheral blood mononuclear cells by prolactin. Endocr J. 2005;52:635–41.PubMedCrossRef Takizawa K, Kitani S, Takeuchi F, Yamamoto K. Enhanced expression of CD69 and CD25 antigen on human peripheral blood mononuclear cells by prolactin. Endocr J. 2005;52:635–41.PubMedCrossRef
36.
Zurück zum Zitat Kochendoerfer SK, Krishnan N, Buckley DJ, Buckley AR. Prolactin regulation of Bcl-2 family members: increased expression of bcl-xL but not mcl-1 or bad in Nb2-T cells. J Endocrinol. 2003;178:265–73.PubMedCrossRef Kochendoerfer SK, Krishnan N, Buckley DJ, Buckley AR. Prolactin regulation of Bcl-2 family members: increased expression of bcl-xL but not mcl-1 or bad in Nb2-T cells. J Endocrinol. 2003;178:265–73.PubMedCrossRef
37.
Zurück zum Zitat Gerlo S, Verdood P, Gellersen B, Hooghe-Peters EL, Kooijman R. Mechanism of prostaglandin (PG)E2-induced prolactin expression in human T cells: cooperation of two PGE2 receptor subtypes, E-prostanoid (EP) 3 and EP4, via calcium- and cyclic adenosine 5′-monophosphate-mediated signaling pathways. J Immunol. 2004;173:5952–62.PubMedCrossRef Gerlo S, Verdood P, Gellersen B, Hooghe-Peters EL, Kooijman R. Mechanism of prostaglandin (PG)E2-induced prolactin expression in human T cells: cooperation of two PGE2 receptor subtypes, E-prostanoid (EP) 3 and EP4, via calcium- and cyclic adenosine 5′-monophosphate-mediated signaling pathways. J Immunol. 2004;173:5952–62.PubMedCrossRef
38.
Zurück zum Zitat Morales P, Carretero MV, Geronimo H, Copín SG, Gaspar ML, Marcos MA, et al. Influence of prolactin on the differentiation of mouse B-lymphoid precursors. Cell Growth Differ. 1999;10:583–90.PubMed Morales P, Carretero MV, Geronimo H, Copín SG, Gaspar ML, Marcos MA, et al. Influence of prolactin on the differentiation of mouse B-lymphoid precursors. Cell Growth Differ. 1999;10:583–90.PubMed
39.
Zurück zum Zitat Chavez-Rueda K, Hérnández J, Zenteno E, Leaños-Miranda A, Legorreta-Haquet MV, Blanco-Favela F. Identification of prolactin as a novel immunomodulator on the expression of co-stimulatory molecules and cytokine secretions on T and B human lymphocytes. Clin Immunol. 2005;116:182–91.PubMedCrossRef Chavez-Rueda K, Hérnández J, Zenteno E, Leaños-Miranda A, Legorreta-Haquet MV, Blanco-Favela F. Identification of prolactin as a novel immunomodulator on the expression of co-stimulatory molecules and cytokine secretions on T and B human lymphocytes. Clin Immunol. 2005;116:182–91.PubMedCrossRef
40.
Zurück zum Zitat Gonzalez J, Saha S, Peeva E. Prolactin rescues and primes autoreactive B cells directly and indirectly through dendritic cells in B6.Sle3 mice. Clin Exp Immunol. 2013;172:311–20.PubMedPubMedCentralCrossRef Gonzalez J, Saha S, Peeva E. Prolactin rescues and primes autoreactive B cells directly and indirectly through dendritic cells in B6.Sle3 mice. Clin Exp Immunol. 2013;172:311–20.PubMedPubMedCentralCrossRef
41.
Zurück zum Zitat Hartwell HJ, Petrosky KY, Fox JG, Horseman ND, Rogers AB. Prolactin prevents hepatocellular carcinoma by restricting innate immune activation of c-Myc in mice. Proc Natl Acad Sci U S A. 2014;111:11455–60.PubMedPubMedCentralCrossRef Hartwell HJ, Petrosky KY, Fox JG, Horseman ND, Rogers AB. Prolactin prevents hepatocellular carcinoma by restricting innate immune activation of c-Myc in mice. Proc Natl Acad Sci U S A. 2014;111:11455–60.PubMedPubMedCentralCrossRef
42.
Zurück zum Zitat Adán N, Guzmán-Morales J, Ledesma-Colunga MG, Perales-Canales SI, Quintanar-Stéphano A, López-Barrera F, et al. Prolactin promotes cartilage survival and attenuates inflammation in inflammatory arthritis. J Clin Invest. 2013;123:3902–13.PubMedPubMedCentralCrossRef Adán N, Guzmán-Morales J, Ledesma-Colunga MG, Perales-Canales SI, Quintanar-Stéphano A, López-Barrera F, et al. Prolactin promotes cartilage survival and attenuates inflammation in inflammatory arthritis. J Clin Invest. 2013;123:3902–13.PubMedPubMedCentralCrossRef
43.
Zurück zum Zitat McCoy JM, Walkenhorst DE, McCauley KS, Elaasar H, Everett JR, Mix KS. Orphan nuclear receptor NR4A2 induces transcription of the immunomodulatory peptide hormone prolactin. J Inflamm (Lond). 2015;12:13. doi:10.1186/s12950-015-0059-2. McCoy JM, Walkenhorst DE, McCauley KS, Elaasar H, Everett JR, Mix KS. Orphan nuclear receptor NR4A2 induces transcription of the immunomodulatory peptide hormone prolactin. J Inflamm (Lond). 2015;12:13. doi:10.​1186/​s12950-015-0059-2.
44.
Zurück zum Zitat López-Rincón G, Pereira-Suárez AL, Del Toro-Arreola S, Sánchez-Hernández PE, Ochoa-Zarzosa A, Muñoz-Valle JF, et al. Lipopolysaccharide induces the expression of an autocrine prolactin loop enhancing inflammatory response in monocytes. J Inflamm (Lond). 2013;10:24. doi:10.1186/1476-9255-10-24. López-Rincón G, Pereira-Suárez AL, Del Toro-Arreola S, Sánchez-Hernández PE, Ochoa-Zarzosa A, Muñoz-Valle JF, et al. Lipopolysaccharide induces the expression of an autocrine prolactin loop enhancing inflammatory response in monocytes. J Inflamm (Lond). 2013;10:24. doi:10.​1186/​1476-9255-10-24.
45.
Zurück zum Zitat Costanza M, Binart N, Steinman L, Pedotti R. Prolactin: a versatile regulator of inflammation and autoimmune pathology. Autoimmun Rev. 2015;14:223–30.PubMedCrossRef Costanza M, Binart N, Steinman L, Pedotti R. Prolactin: a versatile regulator of inflammation and autoimmune pathology. Autoimmun Rev. 2015;14:223–30.PubMedCrossRef
46.
Zurück zum Zitat Pereira Suarez AL, López-Rincón G, Martínez Neri PA, Estrada-Chávez C. Prolactin in inflammatory response. Adv Exp Med Biol. 2015;846:243–64.PubMedCrossRef Pereira Suarez AL, López-Rincón G, Martínez Neri PA, Estrada-Chávez C. Prolactin in inflammatory response. Adv Exp Med Biol. 2015;846:243–64.PubMedCrossRef
47.
Zurück zum Zitat Brennan P, Hajeer A, Ong KR, Worthington J, John S, Thomson W, et al. Allelic markers close to prolactin are associated with HLA-DRB1 susceptibility alleles among women with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Rheum. 1997;40:1383–6.PubMedCrossRef Brennan P, Hajeer A, Ong KR, Worthington J, John S, Thomson W, et al. Allelic markers close to prolactin are associated with HLA-DRB1 susceptibility alleles among women with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Rheum. 1997;40:1383–6.PubMedCrossRef
48.
Zurück zum Zitat Stevens A, Ray D, Alansari A, Hajeer A, Thomson W, Donn R, et al. Characterization of a prolactin gene polymorphism and its associations with systemic lupus erythematosus. Arthritis Rheum. 2001;44:2358–66.PubMedCrossRef Stevens A, Ray D, Alansari A, Hajeer A, Thomson W, Donn R, et al. Characterization of a prolactin gene polymorphism and its associations with systemic lupus erythematosus. Arthritis Rheum. 2001;44:2358–66.PubMedCrossRef
49.
Zurück zum Zitat Mellai M, Giordano M, D’Alfonso S, Marchini M, Scorza R, Giovanna Danieli M, et al. Prolactin and prolactin receptor gene polymorphisms in multiple sclerosis and systemic lupus erythematosus. Hum Immunol. 2003;64:274–84.PubMedCrossRef Mellai M, Giordano M, D’Alfonso S, Marchini M, Scorza R, Giovanna Danieli M, et al. Prolactin and prolactin receptor gene polymorphisms in multiple sclerosis and systemic lupus erythematosus. Hum Immunol. 2003;64:274–84.PubMedCrossRef
50.
Zurück zum Zitat Montoya-Diaz E, Cervera-Castillo H, Chávez-Sánchez L, Legorreta-Haquet MV, Sánchez-González L, Chávez-Rueda K, et al. Prolactin promoter polymorphism (-1149 G/T) is associated with anti-DNA antibodies in Mexican patients with systemic lupus erythematosus. Immunol Investig. 2011;40:614–26.CrossRef Montoya-Diaz E, Cervera-Castillo H, Chávez-Sánchez L, Legorreta-Haquet MV, Sánchez-González L, Chávez-Rueda K, et al. Prolactin promoter polymorphism (-1149 G/T) is associated with anti-DNA antibodies in Mexican patients with systemic lupus erythematosus. Immunol Investig. 2011;40:614–26.CrossRef
51.
Zurück zum Zitat Lee YH, Bae SC, Song GG. Meta-analysis of associations between functional prolactin -1149 G/T polymorphism and susceptibility to rheumatoid arthritis and systemic lupus erythematosus. Clin Rheumatol. 2015;34:683–90.PubMedCrossRef Lee YH, Bae SC, Song GG. Meta-analysis of associations between functional prolactin -1149 G/T polymorphism and susceptibility to rheumatoid arthritis and systemic lupus erythematosus. Clin Rheumatol. 2015;34:683–90.PubMedCrossRef
52.
Zurück zum Zitat Treadwell EL, Wiley K, Word B, Melchior W, Tolleson WH, Gopee N, et al. Prolactin and Dehydroepiandrosterone Levels in Women with Systemic Lupus Erythematosus: The Role of the Extrapituitary Prolactin Promoter Polymorphism at -1149G/T. J Immunol Res. 2015;2015:435658. doi:10.1155/2015/435658. Treadwell EL, Wiley K, Word B, Melchior W, Tolleson WH, Gopee N, et al. Prolactin and Dehydroepiandrosterone Levels in Women with Systemic Lupus Erythematosus: The Role of the Extrapituitary Prolactin Promoter Polymorphism at -1149G/T. J Immunol Res. 2015;2015:435658. doi:10.​1155/​2015/​435658.
53.
Zurück zum Zitat McMurray R, Keisler D, Kanuckel K, Izui S, Walker SE. Prolactin influences autoimmune disease activity in the female B/W mouse. J Immunol. 1991;147:3780–7.PubMed McMurray R, Keisler D, Kanuckel K, Izui S, Walker SE. Prolactin influences autoimmune disease activity in the female B/W mouse. J Immunol. 1991;147:3780–7.PubMed
54.
Zurück zum Zitat Blank M, Krause I, Buskila D, Teitelbaum D, Kopolovic J, Afek A, et al. Bromocriptine immunomodulation of experimental SLE and primary antiphospholipid syndrome via induction of nonspecific T suppressor cells. Cell Immunol. 1995;162:114–22.PubMedCrossRef Blank M, Krause I, Buskila D, Teitelbaum D, Kopolovic J, Afek A, et al. Bromocriptine immunomodulation of experimental SLE and primary antiphospholipid syndrome via induction of nonspecific T suppressor cells. Cell Immunol. 1995;162:114–22.PubMedCrossRef
55.
56.
57.
58.
Zurück zum Zitat Peeva E, Zouali M. Spotlight on the role of hormonal factors in the emergence of autoreactive B-lymphocytes. Immunol Lett. 2005;101:123–43.PubMedCrossRef Peeva E, Zouali M. Spotlight on the role of hormonal factors in the emergence of autoreactive B-lymphocytes. Immunol Lett. 2005;101:123–43.PubMedCrossRef
59.
Zurück zum Zitat Legorreta-Haquet MV, Flores-Fernández R, Blanco-Favela F, Fuentes-Pananá EM, Chávez-Sánchez L, Hernández-González R, et al. Prolactin levels correlate with abnormal B cell maturation in MRL and MRL/lpr mouse models of systemic lupus erythematosus-like disease. Clin Dev Immunol. 2013;2013:287469.PubMedPubMedCentralCrossRef Legorreta-Haquet MV, Flores-Fernández R, Blanco-Favela F, Fuentes-Pananá EM, Chávez-Sánchez L, Hernández-González R, et al. Prolactin levels correlate with abnormal B cell maturation in MRL and MRL/lpr mouse models of systemic lupus erythematosus-like disease. Clin Dev Immunol. 2013;2013:287469.PubMedPubMedCentralCrossRef
60.
Zurück zum Zitat Lavalle C, Loyo E, Paniagua R, Bermudez JA, Herrera J, Graef A, et al. Correlation study between prolactin and androgens in male patients with systemic lupus erythematosus. J Rheumatol. 1987;14:268–72.PubMed Lavalle C, Loyo E, Paniagua R, Bermudez JA, Herrera J, Graef A, et al. Correlation study between prolactin and androgens in male patients with systemic lupus erythematosus. J Rheumatol. 1987;14:268–72.PubMed
61.
Zurück zum Zitat Walker SE, Jacobson JD. Roles of prolactin and gonadotropin-releasing hormone in rheumatic diseases. Rheum Dis Clin N Am. 2000;26:713–36.CrossRef Walker SE, Jacobson JD. Roles of prolactin and gonadotropin-releasing hormone in rheumatic diseases. Rheum Dis Clin N Am. 2000;26:713–36.CrossRef
62.
Zurück zum Zitat Jara LJ, Gomez-Sanchez C, Silveira LH, Martinez-Osuna P, Vasey FB, Espinoza LR. Hyperprolactinemia in systemic lupus erythematosus: association with disease activity. Am J Med Sci. 1992;303:222–6.PubMedCrossRef Jara LJ, Gomez-Sanchez C, Silveira LH, Martinez-Osuna P, Vasey FB, Espinoza LR. Hyperprolactinemia in systemic lupus erythematosus: association with disease activity. Am J Med Sci. 1992;303:222–6.PubMedCrossRef
63.
Zurück zum Zitat Jara LJ, Vera-Lastra O, Miranda JM, Alcala M, Alvarez-Nemegyei J. Prolactin in human systemic lupus erythematosus. Lupus. 2001;10:748–56.PubMedCrossRef Jara LJ, Vera-Lastra O, Miranda JM, Alcala M, Alvarez-Nemegyei J. Prolactin in human systemic lupus erythematosus. Lupus. 2001;10:748–56.PubMedCrossRef
64.
Zurück zum Zitat Blanco-Favela F, Quintal-Alvarez G, Leaños-Miranda A. Association between prolactin and disease activity in systemic lupus erythematosus. Influence of statistical power. J Rheumatol. 1999;26:55–9.PubMed Blanco-Favela F, Quintal-Alvarez G, Leaños-Miranda A. Association between prolactin and disease activity in systemic lupus erythematosus. Influence of statistical power. J Rheumatol. 1999;26:55–9.PubMed
65.
Zurück zum Zitat Blanco-Favela F, Chavez-Rueda K, Leaños-Miranda A. Analysis of anti-prolactin autoantibodies in systemic lupus erythematosus. Lupus. 2001;10:757–61.PubMedCrossRef Blanco-Favela F, Chavez-Rueda K, Leaños-Miranda A. Analysis of anti-prolactin autoantibodies in systemic lupus erythematosus. Lupus. 2001;10:757–61.PubMedCrossRef
66.
Zurück zum Zitat Leaños-Miranda A, Pascoe-Lira D, Chávez-Rueda KA, Blanco-Favela F. Antiprolactin autoantibodies in systemic lupus erythematosus: frequency and correlation with prolactinemia and disease activity. J Rheumatol. 2001;28:1546–53.PubMed Leaños-Miranda A, Pascoe-Lira D, Chávez-Rueda KA, Blanco-Favela F. Antiprolactin autoantibodies in systemic lupus erythematosus: frequency and correlation with prolactinemia and disease activity. J Rheumatol. 2001;28:1546–53.PubMed
67.
Zurück zum Zitat Jacobi AM, Rohde W, Ventz M, Riemekasten G, Burmester GR, Hiepe F. Enhanced serum prolactin (PRL) in patients with systemic lupus erythematosus: PRL levels are related to the disease activity. Lupus. 2001;10:554–61.PubMedCrossRef Jacobi AM, Rohde W, Ventz M, Riemekasten G, Burmester GR, Hiepe F. Enhanced serum prolactin (PRL) in patients with systemic lupus erythematosus: PRL levels are related to the disease activity. Lupus. 2001;10:554–61.PubMedCrossRef
68.
Zurück zum Zitat Pacilio M, Migliaresi S, Meli R, Ambrosone L, Bigliardo B, Di Carlo R. Elevated bioactive prolactin levels in systemic lupus erythematosus—association with disease activity. J Rheumatol. 2001;28:2216–21.PubMed Pacilio M, Migliaresi S, Meli R, Ambrosone L, Bigliardo B, Di Carlo R. Elevated bioactive prolactin levels in systemic lupus erythematosus—association with disease activity. J Rheumatol. 2001;28:2216–21.PubMed
69.
Zurück zum Zitat Miranda JM, Prieto RE, Paniagua R, Garcia G, Amato D, Barile L, et al. Clinical significance of serum and urine prolactin levels in lupus glomerulonephritis. Lupus. 1998;7:387–91. Miranda JM, Prieto RE, Paniagua R, Garcia G, Amato D, Barile L, et al. Clinical significance of serum and urine prolactin levels in lupus glomerulonephritis. Lupus. 1998;7:387–91.
70.
Zurück zum Zitat Jara LJ, Irigoyen L, Ortiz MJ, Zazueta B, Bravo G, Espinoza LR. Prolactin and interleukin-6 in neuropsychiatric lupus erythematosus. Clin Rheumatol. 1998;17:110–4.PubMedCrossRef Jara LJ, Irigoyen L, Ortiz MJ, Zazueta B, Bravo G, Espinoza LR. Prolactin and interleukin-6 in neuropsychiatric lupus erythematosus. Clin Rheumatol. 1998;17:110–4.PubMedCrossRef
71.
Zurück zum Zitat Vera-Lastra O, Mendez C, Jara LJ, Cisneros M, Medina G, Ariza R, et al. Correlation of prolactin serum concentrations with clinical activity and remission in patients with systemic lupus erythematosus. Effect of conventional treatment. J Rheumatol. 2003;30:2140–6.PubMed Vera-Lastra O, Mendez C, Jara LJ, Cisneros M, Medina G, Ariza R, et al. Correlation of prolactin serum concentrations with clinical activity and remission in patients with systemic lupus erythematosus. Effect of conventional treatment. J Rheumatol. 2003;30:2140–6.PubMed
72.
Zurück zum Zitat Rezaieyazdi Z, Hesamifard A. Correlation between serum prolactin levels and lupus activity. Rheumatol Int. 2006;26:1036–9.PubMedCrossRef Rezaieyazdi Z, Hesamifard A. Correlation between serum prolactin levels and lupus activity. Rheumatol Int. 2006;26:1036–9.PubMedCrossRef
73.
Zurück zum Zitat Sugiura K, Muro Y, Watanabe A, Tomita Y. A case of systemic lupus erythematosus: continued association of circulating prolactin levels with disease activity over a 4-year follow-up period. Mod Rheumatol. 2005;15:220–2.PubMedCrossRef Sugiura K, Muro Y, Watanabe A, Tomita Y. A case of systemic lupus erythematosus: continued association of circulating prolactin levels with disease activity over a 4-year follow-up period. Mod Rheumatol. 2005;15:220–2.PubMedCrossRef
74.
Zurück zum Zitat Cardenas-Mondragon G, Ulloa-Aguirre A, Isordia-Salas I, Goffin V, Leaños-Miranda A. Elevated serum bioactive prolactin concentrations in patients with systemic lupus erythematosus are associated with disease activity as disclosed by homologous receptor bioassays. J Rheumatol. 2007;34:1514–21.PubMed Cardenas-Mondragon G, Ulloa-Aguirre A, Isordia-Salas I, Goffin V, Leaños-Miranda A. Elevated serum bioactive prolactin concentrations in patients with systemic lupus erythematosus are associated with disease activity as disclosed by homologous receptor bioassays. J Rheumatol. 2007;34:1514–21.PubMed
75.
Zurück zum Zitat Shabanova SS, Ananieva LP, Alekberova ZS, Guzov II. Ovarian function and disease activity in patients with systemic lupus erythematosus. Clin Exp Rheumatol. 2008;26:436–41.PubMed Shabanova SS, Ananieva LP, Alekberova ZS, Guzov II. Ovarian function and disease activity in patients with systemic lupus erythematosus. Clin Exp Rheumatol. 2008;26:436–41.PubMed
76.
Zurück zum Zitat Silva CA, Deen ME, Febrônio MV, Oliveira SK, Terreri MT, Sacchetti SB, et al. Hormone profile in juvenile systemic lupus erythematosus with previous or current amenorrhea. Rheumatol Int. 2011;31:1037–43.PubMedCrossRef Silva CA, Deen ME, Febrônio MV, Oliveira SK, Terreri MT, Sacchetti SB, et al. Hormone profile in juvenile systemic lupus erythematosus with previous or current amenorrhea. Rheumatol Int. 2011;31:1037–43.PubMedCrossRef
77.
Zurück zum Zitat Paraiba DB, Soares CR, Bartolini P, Arthuso FS, Borba EF, Bonfa E, et al. Lymphocytic prolactin does not contribute to systemic lupus erythematosus hyperprolactinemia. Clin Exp Rheumatol. 2010;28:866–72.PubMed Paraiba DB, Soares CR, Bartolini P, Arthuso FS, Borba EF, Bonfa E, et al. Lymphocytic prolactin does not contribute to systemic lupus erythematosus hyperprolactinemia. Clin Exp Rheumatol. 2010;28:866–72.PubMed
78.
Zurück zum Zitat Yang J, Li Q, Yang X, Li M. Increased serum level of prolactin is related to autoantibody production in systemic lupus erythematosus. Lupus. 2016;25:513–9.PubMedCrossRef Yang J, Li Q, Yang X, Li M. Increased serum level of prolactin is related to autoantibody production in systemic lupus erythematosus. Lupus. 2016;25:513–9.PubMedCrossRef
79.
Zurück zum Zitat Legorreta-Haquet MV, Chávez-Rueda K, Chávez-Sánchez L, Cervera-Castillo H, Zenteno-Galindo E, Barile-Fabris L, et al. Function of Treg Cells Decreased in Patients With Systemic Lupus Erythematosus Due To the Effect of Prolactin. Medicine (Baltimore). 2016;95:e2384. doi:10.1097/MD.0000000000002384. Legorreta-Haquet MV, Chávez-Rueda K, Chávez-Sánchez L, Cervera-Castillo H, Zenteno-Galindo E, Barile-Fabris L, et al. Function of Treg Cells Decreased in Patients With Systemic Lupus Erythematosus Due To the Effect of Prolactin. Medicine (Baltimore). 2016;95:e2384. doi:10.​1097/​MD.​0000000000002384​.
80.
Zurück zum Zitat Toffoli Ribeiro C, Louzada Júnior P, de Sá MF. Correlation between systemic lupus erythematosus activity and plasma levels of monomeric prolactin and macroprolactin. Endocr Metab Immune Disord Drug Targets. 2016;16:21–7.PubMedCrossRef Toffoli Ribeiro C, Louzada Júnior P, de Sá MF. Correlation between systemic lupus erythematosus activity and plasma levels of monomeric prolactin and macroprolactin. Endocr Metab Immune Disord Drug Targets. 2016;16:21–7.PubMedCrossRef
81.
Zurück zum Zitat Orbach H, Zandman-Goddard G, Boaz M, Agmon-Levin N, Amital H, Szekanecz Z, et al. Prolactin and autoimmunity: hyperprolactinemia correlates with serositis and anemia in SLE patients. Clin Rev Allergy Immunol. 2012;42:189–98.PubMedCrossRef Orbach H, Zandman-Goddard G, Boaz M, Agmon-Levin N, Amital H, Szekanecz Z, et al. Prolactin and autoimmunity: hyperprolactinemia correlates with serositis and anemia in SLE patients. Clin Rev Allergy Immunol. 2012;42:189–98.PubMedCrossRef
82.
Zurück zum Zitat Zhang LN, Shi TY, Yang YJ, Zhang FC. An SLE patient with prolactinoma and recurrent granulomatous mastitis successfully treated with hydroxychloroquine and bromocriptine. Lupus. 2014;23:417–20.PubMedCrossRef Zhang LN, Shi TY, Yang YJ, Zhang FC. An SLE patient with prolactinoma and recurrent granulomatous mastitis successfully treated with hydroxychloroquine and bromocriptine. Lupus. 2014;23:417–20.PubMedCrossRef
83.
Zurück zum Zitat Nadira U, Cader RA, Kong NC, Mohd R, Gafor HA. Systemic lupus erythematosus with a non functioning pituitary macroadenoma. Am J Case Rep. 2012;13:160–2.PubMedPubMedCentralCrossRef Nadira U, Cader RA, Kong NC, Mohd R, Gafor HA. Systemic lupus erythematosus with a non functioning pituitary macroadenoma. Am J Case Rep. 2012;13:160–2.PubMedPubMedCentralCrossRef
84.
Zurück zum Zitat Reuman PD. First reported pediatric case of systemic lupus erythematosus associated with prolactinoma. Arthritis Rheum. 2004;50:3616–8.PubMedCrossRef Reuman PD. First reported pediatric case of systemic lupus erythematosus associated with prolactinoma. Arthritis Rheum. 2004;50:3616–8.PubMedCrossRef
85.
Zurück zum Zitat Ugarte-Gil MF, Gamboa-Cárdenas RV, Zevallos F, Medina M, Cucho-Venegas JM, Perich-Campos RA, et al. High prolactin levels are independently associated with damage accrual in systemic lupus erythematosus patients. Lupus. 2014;23:969–74.PubMedCrossRef Ugarte-Gil MF, Gamboa-Cárdenas RV, Zevallos F, Medina M, Cucho-Venegas JM, Perich-Campos RA, et al. High prolactin levels are independently associated with damage accrual in systemic lupus erythematosus patients. Lupus. 2014;23:969–74.PubMedCrossRef
86.
Zurück zum Zitat Gutierrez MA, Molina JF, Jara LJ, Cuéllar ML, García C, Gutiérrez-Ureña S, et al. Prolactin and systemic lupus erythematosus: prolactin secretion by SLE lymphocytes and proliferative (autocrine) activity. Lupus. 1995;4:348–52.PubMedCrossRef Gutierrez MA, Molina JF, Jara LJ, Cuéllar ML, García C, Gutiérrez-Ureña S, et al. Prolactin and systemic lupus erythematosus: prolactin secretion by SLE lymphocytes and proliferative (autocrine) activity. Lupus. 1995;4:348–52.PubMedCrossRef
87.
Zurück zum Zitat Larrea F, Martínez-Castillo A, Cabrera V, Alcocer-Varela J, Queipo G, Cariño C, et al. A bioactive 60-kilodalton prolactin species is preferentially secreted in cultures of mitogen-stimulated and nonstimulated peripheral blood mononuclear cells from subjects with systemic lupus erythematosus. J Clin Endocrinol Metab. 1997;82:3664–9.PubMed Larrea F, Martínez-Castillo A, Cabrera V, Alcocer-Varela J, Queipo G, Cariño C, et al. A bioactive 60-kilodalton prolactin species is preferentially secreted in cultures of mitogen-stimulated and nonstimulated peripheral blood mononuclear cells from subjects with systemic lupus erythematosus. J Clin Endocrinol Metab. 1997;82:3664–9.PubMed
88.
Zurück zum Zitat Cruz J, Aviña-Zubieta A, Martínez de la Escalera G, Clapp C, Lavalle C. Molecular heterogeneity of prolactin in the plasma of patients with systemic lupus erythematosus. Arthritis Rheum. 2001;44:1331–5.PubMedCrossRef Cruz J, Aviña-Zubieta A, Martínez de la Escalera G, Clapp C, Lavalle C. Molecular heterogeneity of prolactin in the plasma of patients with systemic lupus erythematosus. Arthritis Rheum. 2001;44:1331–5.PubMedCrossRef
89.
Zurück zum Zitat Leaños-Miranda A, Cardenas-Mondragon G. Serum free prolactin concentrations in patients with systemic lupus erythematosus are associated with lupus activity. Rheumatology (Oxford). 2006;45:97–101.CrossRef Leaños-Miranda A, Cardenas-Mondragon G. Serum free prolactin concentrations in patients with systemic lupus erythematosus are associated with lupus activity. Rheumatology (Oxford). 2006;45:97–101.CrossRef
90.
Zurück zum Zitat Garcia M, Colombani-Vidal ME, Zylbersztein CC, Testi A, Marcos J, Arturi A, et al. Analysis of molecular heterogeneity of prolactin in human systemic lupus erythematosus. Lupus. 2004;13:575–83.PubMedCrossRef Garcia M, Colombani-Vidal ME, Zylbersztein CC, Testi A, Marcos J, Arturi A, et al. Analysis of molecular heterogeneity of prolactin in human systemic lupus erythematosus. Lupus. 2004;13:575–83.PubMedCrossRef
92.
Zurück zum Zitat Mendez I, Alcocer-Varela J, Parra A, Lava-Zavala A, de la Cruz DA, Alarcón-Segovia D, et al. Neuroendocrine dopaminergic regulation of prolactin release in systemic lupus erythematosus: a possible role of lymphocyte-derived prolactin. Lupus. 2004;13:45–53.PubMedCrossRef Mendez I, Alcocer-Varela J, Parra A, Lava-Zavala A, de la Cruz DA, Alarcón-Segovia D, et al. Neuroendocrine dopaminergic regulation of prolactin release in systemic lupus erythematosus: a possible role of lymphocyte-derived prolactin. Lupus. 2004;13:45–53.PubMedCrossRef
93.
Zurück zum Zitat Huang X, Guo Y, Bao C, Shen N. Multidimensional single cell based STAT phosphorylation profiling identifies a novel biosignature for evaluation of systemic lupus erythematosus activity. PLoS One. 2011;6:e21671.PubMedPubMedCentralCrossRef Huang X, Guo Y, Bao C, Shen N. Multidimensional single cell based STAT phosphorylation profiling identifies a novel biosignature for evaluation of systemic lupus erythematosus activity. PLoS One. 2011;6:e21671.PubMedPubMedCentralCrossRef
94.
Zurück zum Zitat Gado K, Rimanóczi E, Hasitz A, Gigler G, Tóth BE, Nagy GM, et al. Elevated levels of serum prolactin in patients with advanced multiple myeloma. Neuroimmunomodulation. 2001;9:231–6.PubMedCrossRef Gado K, Rimanóczi E, Hasitz A, Gigler G, Tóth BE, Nagy GM, et al. Elevated levels of serum prolactin in patients with advanced multiple myeloma. Neuroimmunomodulation. 2001;9:231–6.PubMedCrossRef
95.
Zurück zum Zitat Jacobi AM, Rohde W, Volk HD, Dörner T, Burmester GR, Hiepe F. Prolactin enhances the in vitro production of IgG in peripheral blood mononuclear cells from patients with systemic lupus erythematosus but not from healthy controls. Ann Rheum Dis. 2001;60:242–7.PubMedPubMedCentralCrossRef Jacobi AM, Rohde W, Volk HD, Dörner T, Burmester GR, Hiepe F. Prolactin enhances the in vitro production of IgG in peripheral blood mononuclear cells from patients with systemic lupus erythematosus but not from healthy controls. Ann Rheum Dis. 2001;60:242–7.PubMedPubMedCentralCrossRef
96.
Zurück zum Zitat Chavez-Rueda K, Legorreta-Haquet MV, Cervera-Castillo H, Sánchez L, Jara LJ, Zenteno E, et al. Prolactin effect on CD69 and CD154 expression by CD4+ cells from systemic lupus erythematosus patients. Clin Exp Rheumatol. 2005;23:769–77.PubMed Chavez-Rueda K, Legorreta-Haquet MV, Cervera-Castillo H, Sánchez L, Jara LJ, Zenteno E, et al. Prolactin effect on CD69 and CD154 expression by CD4+ cells from systemic lupus erythematosus patients. Clin Exp Rheumatol. 2005;23:769–77.PubMed
97.
Zurück zum Zitat McMurray RW, Allen SH, Braun AL, Rodriguez F, Walker SE. Longstanding hyperprolactinemia associated with systemic lupus erythematosus: possible hormonal stimulation of an autoimmune disease. J Rheumatol. 1994;21:843–50.PubMed McMurray RW, Allen SH, Braun AL, Rodriguez F, Walker SE. Longstanding hyperprolactinemia associated with systemic lupus erythematosus: possible hormonal stimulation of an autoimmune disease. J Rheumatol. 1994;21:843–50.PubMed
98.
Zurück zum Zitat Anaya JM, Shoenfeld Y. Multiple autoimmune disease in a patient with hyperprolactinemia. Isr Med Assoc J. 2005;7:740–1.PubMed Anaya JM, Shoenfeld Y. Multiple autoimmune disease in a patient with hyperprolactinemia. Isr Med Assoc J. 2005;7:740–1.PubMed
99.
Zurück zum Zitat Egli M, Leeners B, Kruger TH. Prolactin secretion patterns: basic mechanisms and clinical implications for reproduction. Reproduction. 2010;140:643–54.PubMedCrossRef Egli M, Leeners B, Kruger TH. Prolactin secretion patterns: basic mechanisms and clinical implications for reproduction. Reproduction. 2010;140:643–54.PubMedCrossRef
100.
Zurück zum Zitat Zen M, Ghirardello A, Iaccarino L, Tonon M, Campana C, Arienti S, et al. Hormones, immune response, and pregnancy in healthy women and SLE patients. Swiss Med Wkly. 2010;140:187–201.PubMed Zen M, Ghirardello A, Iaccarino L, Tonon M, Campana C, Arienti S, et al. Hormones, immune response, and pregnancy in healthy women and SLE patients. Swiss Med Wkly. 2010;140:187–201.PubMed
101.
Zurück zum Zitat Crowley WR. Neuroendocrine regulation of lactation and milk production. Compr Physiol. 2015;5:255–91.PubMed Crowley WR. Neuroendocrine regulation of lactation and milk production. Compr Physiol. 2015;5:255–91.PubMed
102.
Zurück zum Zitat Torner L, Toschi N, Nava G, Clapp C, Neumann ID. Increased hypothalamic expression of prolactin in lactation: involvement in behavioural and neuroendocrine stress responses. Eur J Neurosci. 2002;15:1381–9.PubMedCrossRef Torner L, Toschi N, Nava G, Clapp C, Neumann ID. Increased hypothalamic expression of prolactin in lactation: involvement in behavioural and neuroendocrine stress responses. Eur J Neurosci. 2002;15:1381–9.PubMedCrossRef
103.
Zurück zum Zitat Martinez-Garcia EA, Sánchez-Hernández PE, Chavez-Robles B, Nuñez-Atahualpa L, Martín-Márquez BT, Arana-Argaez VE, et al. The distribution of CD56(dim) CD16+ and CD56(bright) CD16- cells are associated with prolactin levels during pregnancy and menstrual cycle in healthy women. Am J Reprod Immunol. 2011;65:433–7.PubMedCrossRef Martinez-Garcia EA, Sánchez-Hernández PE, Chavez-Robles B, Nuñez-Atahualpa L, Martín-Márquez BT, Arana-Argaez VE, et al. The distribution of CD56(dim) CD16+ and CD56(bright) CD16- cells are associated with prolactin levels during pregnancy and menstrual cycle in healthy women. Am J Reprod Immunol. 2011;65:433–7.PubMedCrossRef
104.
Zurück zum Zitat Saavedra MA, Sánchez A, Morales S, Navarro-Zarza JE, Ángeles U, Jara LJ. Primigravida is associated with flare in women with systemic lupus erythematosus. Lupus. 2015;24:180–5.PubMedCrossRef Saavedra MA, Sánchez A, Morales S, Navarro-Zarza JE, Ángeles U, Jara LJ. Primigravida is associated with flare in women with systemic lupus erythematosus. Lupus. 2015;24:180–5.PubMedCrossRef
105.
Zurück zum Zitat Jara LJ, Medina G, Cruz-Dominguez P, Navarro C, Vera-Lastra O, Saavedra MA. Risk factors of systemic lupus erythematosus flares during pregnancy. Immunol Res. 2014;60:184–92.PubMedCrossRef Jara LJ, Medina G, Cruz-Dominguez P, Navarro C, Vera-Lastra O, Saavedra MA. Risk factors of systemic lupus erythematosus flares during pregnancy. Immunol Res. 2014;60:184–92.PubMedCrossRef
106.
Zurück zum Zitat Jara-Quezada L, Graef A, Lavalle C. Prolactin and gonadal hormones during pregnancy in systemic lupus erythematosus. J Rheumatol. 1991;18:349–53.PubMed Jara-Quezada L, Graef A, Lavalle C. Prolactin and gonadal hormones during pregnancy in systemic lupus erythematosus. J Rheumatol. 1991;18:349–53.PubMed
107.
Zurück zum Zitat Doria A, Cutolo M, Ghirardello A, Zampieri S, Vescovi F, Sulli A, et al. Steroid hormones and disease activity during pregnancy in systemic lupus erythematosus. Arthritis Rheum. 2002;47:202–9.PubMedCrossRef Doria A, Cutolo M, Ghirardello A, Zampieri S, Vescovi F, Sulli A, et al. Steroid hormones and disease activity during pregnancy in systemic lupus erythematosus. Arthritis Rheum. 2002;47:202–9.PubMedCrossRef
108.
Zurück zum Zitat Jara LJ, Pacheco-Reyes H, Medina G, Angeles U, Cruz-Cruz P, Saavedra MA. Prolactin levels are associated with lupus activity, lupus anticoagulant, and poor outcome in pregnancy. Ann N Y Acad Sci. 2007;1108:218–26.PubMedCrossRef Jara LJ, Pacheco-Reyes H, Medina G, Angeles U, Cruz-Cruz P, Saavedra MA. Prolactin levels are associated with lupus activity, lupus anticoagulant, and poor outcome in pregnancy. Ann N Y Acad Sci. 2007;1108:218–26.PubMedCrossRef
109.
Zurück zum Zitat Muñoz-Valle JF, Vázquez-Del Mercado M, García-Iglesias T, Orozco-Barocio G, Bernard-Medina G, Martínez-Bonilla G, et al. T(H)1/T(H)2 cytokine profile, metalloprotease-9 activity and hormonal status in pregnant rheumatoid arthritis and systemic lupus erythematosus patients. Clin Exp Immunol. 2003;131:377–84.PubMedPubMedCentralCrossRef Muñoz-Valle JF, Vázquez-Del Mercado M, García-Iglesias T, Orozco-Barocio G, Bernard-Medina G, Martínez-Bonilla G, et al. T(H)1/T(H)2 cytokine profile, metalloprotease-9 activity and hormonal status in pregnant rheumatoid arthritis and systemic lupus erythematosus patients. Clin Exp Immunol. 2003;131:377–84.PubMedPubMedCentralCrossRef
110.
Zurück zum Zitat Leaños-Miranda A, Cárdenas-Mondragón G, Ulloa-Aguirre A, Isordia-Salas I, Parra A, Ramírez-Peredo J. Anti-prolactin autoantibodies in pregnant women with systemic lupus erythematosus: maternal and fetal outcome. Lupus. 2007;16:342-9. Leaños-Miranda A, Cárdenas-Mondragón G, Ulloa-Aguirre A, Isordia-Salas I, Parra A, Ramírez-Peredo J. Anti-prolactin autoantibodies in pregnant women with systemic lupus erythematosus: maternal and fetal outcome. Lupus. 2007;16:342-9.
111.
Zurück zum Zitat Jara LJ, Cruz-Cruz P, Saavedra MA, Medina G, García-Flores A, Angeles U, et al. Bromocriptine during pregnancy in systemic lupus erythematosus: a pilot clinical trial. Ann N Y Acad Sci. 2007;1110:297–304.PubMedCrossRef Jara LJ, Cruz-Cruz P, Saavedra MA, Medina G, García-Flores A, Angeles U, et al. Bromocriptine during pregnancy in systemic lupus erythematosus: a pilot clinical trial. Ann N Y Acad Sci. 2007;1110:297–304.PubMedCrossRef
112.
Zurück zum Zitat Qian Q, Liuqin L, Hao L, Shiwen Y, Zhongping Z, Dongying C, et al. The effects of bromocriptine on preventing postpartum flare in systemic lupus erythematosus patients from South China. J Immunol Res. 2015;2015:316965.PubMedPubMedCentralCrossRef Qian Q, Liuqin L, Hao L, Shiwen Y, Zhongping Z, Dongying C, et al. The effects of bromocriptine on preventing postpartum flare in systemic lupus erythematosus patients from South China. J Immunol Res. 2015;2015:316965.PubMedPubMedCentralCrossRef
113.
Zurück zum Zitat McMurray RW, Keisler D, Izui S, Walker SE. Effects of parturition, suckling and pseudopregnancy on variables of disease activity in the B/W mouse model of systemic lupus erythematosus. J Rheumatol. 1993;20:1143–51.PubMed McMurray RW, Keisler D, Izui S, Walker SE. Effects of parturition, suckling and pseudopregnancy on variables of disease activity in the B/W mouse model of systemic lupus erythematosus. J Rheumatol. 1993;20:1143–51.PubMed
114.
Zurück zum Zitat Berczi I. Prolactin, pregnancy and autoimmune disease. J Rheumatol. 1993;20:1095–100.PubMed Berczi I. Prolactin, pregnancy and autoimmune disease. J Rheumatol. 1993;20:1095–100.PubMed
115.
Zurück zum Zitat Levite M. Dopamine and T cells: dopamine receptors and potent effects on T cells, dopamine production in T cells, and abnormalities in the dopaminergic system in T cells in autoimmune, neurological and psychiatric diseases. Acta Physiol (Oxf). 2016;216:42–89.CrossRef Levite M. Dopamine and T cells: dopamine receptors and potent effects on T cells, dopamine production in T cells, and abnormalities in the dopaminergic system in T cells in autoimmune, neurological and psychiatric diseases. Acta Physiol (Oxf). 2016;216:42–89.CrossRef
117.
Zurück zum Zitat Anderson KK, Ballok DA, Prasad N, Szechtman H, Sakic B. Impaired response to amphetamine and neuronal degeneration in the nucleus accumbens of autoimmune MRL-lpr mice. Behav Brain Res. 2006;166:32–8.PubMedCrossRef Anderson KK, Ballok DA, Prasad N, Szechtman H, Sakic B. Impaired response to amphetamine and neuronal degeneration in the nucleus accumbens of autoimmune MRL-lpr mice. Behav Brain Res. 2006;166:32–8.PubMedCrossRef
118.
Zurück zum Zitat Ballok DA, Earls AM, Krasnik C, Hoffman SA, Sakic B. Autoimmune-induced damage of the midbrain dopaminergic system in lupus-prone mice. J Neuroimmunol. 2004;152:83–97.PubMedCrossRef Ballok DA, Earls AM, Krasnik C, Hoffman SA, Sakic B. Autoimmune-induced damage of the midbrain dopaminergic system in lupus-prone mice. J Neuroimmunol. 2004;152:83–97.PubMedCrossRef
119.
Zurück zum Zitat Ferreira C, Paes M, Gouveia A, Ferreira E, Pádua F, Fiúza T. Plasma homovanillic acid and prolactin in systemic lupus erythematosus. Lupus. 1998;7:392–7.PubMedCrossRef Ferreira C, Paes M, Gouveia A, Ferreira E, Pádua F, Fiúza T. Plasma homovanillic acid and prolactin in systemic lupus erythematosus. Lupus. 1998;7:392–7.PubMedCrossRef
120.
Zurück zum Zitat Jafari M, Ahangari G, Saberi M, Samangoui S, Torabi R, Zouali M. Distorted expression of dopamine receptor genes in systemic lupus erythematosus. Immunobiology. 2013;218:979–83.PubMedCrossRef Jafari M, Ahangari G, Saberi M, Samangoui S, Torabi R, Zouali M. Distorted expression of dopamine receptor genes in systemic lupus erythematosus. Immunobiology. 2013;218:979–83.PubMedCrossRef
121.
Zurück zum Zitat Melmed S, Casanueva FF, Hoffman AR, Kleinberg DL, Montori VM, Schlechte JA, et al. Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96:273–88. Melmed S, Casanueva FF, Hoffman AR, Kleinberg DL, Montori VM, Schlechte JA, et al. Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96:273–88.
122.
123.
Zurück zum Zitat Alvarez-Nemegyei J, Cobarrubias-Cobos A, Escalante-Triay F, Sosa-Muñoz J, Miranda JM, Jara LJ. Bromocriptine in systemic lupus erythematosus: a double-blind, randomized, placebo-controlled study. Lupus. 1998;7:414–9.PubMedCrossRef Alvarez-Nemegyei J, Cobarrubias-Cobos A, Escalante-Triay F, Sosa-Muñoz J, Miranda JM, Jara LJ. Bromocriptine in systemic lupus erythematosus: a double-blind, randomized, placebo-controlled study. Lupus. 1998;7:414–9.PubMedCrossRef
124.
Zurück zum Zitat McMurray RW, Weidensaul D, Allen SH, Walker SE. Efficacy of bromocriptine in an open label therapeutic trial for systemic lupus erythematosus. J Rheumatol. 1995;22:2084–91.PubMed McMurray RW, Weidensaul D, Allen SH, Walker SE. Efficacy of bromocriptine in an open label therapeutic trial for systemic lupus erythematosus. J Rheumatol. 1995;22:2084–91.PubMed
125.
Zurück zum Zitat Walker SE. Modulation of hormones in the treatment of lupus. Am J Manag Care. 2001;7:S486–9.PubMed Walker SE. Modulation of hormones in the treatment of lupus. Am J Manag Care. 2001;7:S486–9.PubMed
126.
Zurück zum Zitat McMurray RW. Bromocriptine in rheumatic and autoimmune diseases. Semin Arthritis Rheum. 2001;31:21–32.PubMedCrossRef McMurray RW. Bromocriptine in rheumatic and autoimmune diseases. Semin Arthritis Rheum. 2001;31:21–32.PubMedCrossRef
127.
Zurück zum Zitat Hrycek A, Cieślik P, Tustanowski J, Nowak S, Jedynak P. Selected serum cytokines in systemic lupus erythematosus treated with quinagolide. Lupus. 2001;10:424–30.PubMedCrossRef Hrycek A, Cieślik P, Tustanowski J, Nowak S, Jedynak P. Selected serum cytokines in systemic lupus erythematosus treated with quinagolide. Lupus. 2001;10:424–30.PubMedCrossRef
128.
Zurück zum Zitat Jara LJ, Medina G, Saavedra MA, Vera-Lastra O, Navarro C. Prolactin and autoimmunity. Clin Rev Allergy Immunol. 2011;40:50–9.PubMedCrossRef Jara LJ, Medina G, Saavedra MA, Vera-Lastra O, Navarro C. Prolactin and autoimmunity. Clin Rev Allergy Immunol. 2011;40:50–9.PubMedCrossRef
Metadaten
Titel
Prolactin has a pathogenic role in systemic lupus erythematosus
verfasst von
Luis J. Jara
Gabriela Medina
Miguel A. Saavedra
Olga Vera-Lastra
Honorio Torres-Aguilar
Carmen Navarro
Monica Vazquez del Mercado
Luis R. Espinoza
Publikationsdatum
28.01.2017
Verlag
Springer US
Erschienen in
Immunologic Research / Ausgabe 2/2017
Print ISSN: 0257-277X
Elektronische ISSN: 1559-0755
DOI
https://doi.org/10.1007/s12026-016-8891-x

Weitere Artikel der Ausgabe 2/2017

Immunologic Research 2/2017 Zur Ausgabe

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.